Microneedles-Based Theranostic Platform: From the Past to the Future

Ziyang Li,Yuhan Wang,Ruiwei Zhang,Zijian Liu,Ziyong Chang,Yulin Deng,Xiaoyue Qi
DOI: https://doi.org/10.1021/acsnano.4c04277
IF: 17.1
2024-08-23
ACS Nano
Abstract:Fully integrated theranostic devices are highly esteemed in clinical applications, offering immense potential in real-time disease monitoring and personalized care. Microneedles (MNs), as innovative and wearable devices, boast important advantages in biosensing and therapy, thus holding significant promise in the advancement of diagnostic and therapeutic platforms. Encouragingly, advancements in electrochemical sensing technology, micronano fabrication, and biocompatible materials are propelling momentum for MNs-based closed-loop systems, enhancing detection capabilities, biocompatibility, and cost-effectiveness. Moreover, the notable progress in integrating MN chips with other biochips signifies a frontier for growth. Successful clinical trials in target molecule monitoring and drug delivery domains herald excellent clinical translational prospects for the aforementioned theranostic platform. Finally, we delineate both challenges and opportunities in the development of integrated diagnostic and therapeutic MN systems, including continuous monitoring, intelligent control algorithms, safety, and regulatory considerations.
What problem does this paper attempt to address?